Mabhenefiti eRamucirumab kune varwere vane yakanyanya AFP kenza yechiropa

Share This Post

Chirwere cheropa

Gomarara rechiropa rinowanzoita vascular-rich bundu, uye bundu tsinga dzeropa dzinoita basa rakakosha mukukura kwegomarara rechiropa. Naizvozvo, iko zvino kwakanangwa kurapwa kwegomarara rechiropa kunoitwa kutenderedza anti-angiogenesis. Anti-angiogenesis kurapa idanho rakakosha mukurapa kwegomarara rechiropa.

SVIKIRA 2 MIEDZO

Muyedzo weREACH-2 unoitwa pahwaro hwemuyedzo weREACH. Muzvinafundo wekuChina wekuAmerica Muzvinafundo Andrew X. Zhu wekuchipatara cheMassachusetts chakabatana neHarvard University kuUnited States anoshanda sePI yepasi rose. For the gomarara rechiropa varwere vakakundikana kubata Sorafenib, kuenzanisa Ramucirumab kwakasiyana ne placebo muhutano hwechipiri-mutsara wekurapa, asi muedzo hauna kuwana zvinotarisirwa. Asi kuongororwa kwayo kweboka kunoratidza kuti varwere vane AFP (alpha-fetoprotein) vanopfuura 400 ng / ml vanogona kubatsirwa neRamucirumab kurapwa. Naizvozvo, Muzvinafundo Zhu akatungamira muyedzo weREACH-2 uye akawana kuti Ramucirumab inobatsira varwere mune zvese mukupona uye kufambira mberi-pasina nguva yekupona kana ichienzaniswa ne placebo. Muedzo uyu une kukosha kwekuita epoch, uye zvakare unoratidza kuti mumutsara wechipiri kurapwa kwegomarara rechiropa, anti-angiogenesis kurapwa ne macromolecular monoclonal antibodies inogona kuwana mabhenefiti ekupona ane chinangwa.

Parizvino, oxaliplatin yakabvumidzwa seyakajairwa chirongwa chekurapa munyika dzese dzemumba neEuropean. Pamishonga midiki-morekuru yakanangwa, sorafenib nelenvatinib zvinogona kushandiswa pakurapa mutsara wekutanga, uye regorafenib necarbotinib zvinoshandiswa pakurapa kwemutsara wechipiri. Kune mahombe-morekuru zvinodhaka, Nivolumab uye Ramucirumab ese ari maviri Sarudza mishonga.

Mukuwedzera, vazhinji vane kenza yechiropa vane hepatitis, uye murwere mumwe chete, nhengo imwechete panguva imwe chete, kune zvirwere zviviri zvakasiyana zvachose. Imwe mhando chirwere chechiropa chakakosha, kusanganisira hepatitis, ingave hutachiona hwehepatitis, kana doro rechiropa chirwere, mafuta echiropa, cirrhosis, panogona kunge paine kusashanda kwechiropa uye mamwe matambudziko. Chikamu chechipiri ndechegomarara rechiropa repamusoro. Zvirwere zviviri izvi zvinobata mumwe nemumwe uye zvinogadzira denderedzwa rakashata. Nokudaro, zvinodikanwa kupa kunyatsofungisisa kuongororwa uye nzira yekurapa, kudzivirira kurasikirwa kweumwe neumwe. Mumakore achangopfuura, zvave zvichitsigirwa kuti kurapa antiviral uye kurapwa kwekudzivirira chiropa kuitwe panguva imwe chete. Uku ndiko kumwe kufambira mberi kwakaitwa mukurapa gomarara rechiropa.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.
kenza

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.

Lutetium Lu 177 dotatate, kurapwa kwepasi, ichangobva kugamuchira mvumo kubva kuUS Food and Drug Administration (FDA) yevarwere vevana, zvichiratidza chiitiko chakakosha muvana oncology. Mvumo iyi inomiririra chiedza chetariro kuvana vari kurwisana neuroendocrine tumors (NETs), isingawanzowanikwi asi inonetsa yegomarara iro rinowanzoratidza kuti rinoshingirira pakurapa kwakajairika.

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.
Chirwere chechirwere

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.

"Nogapendekin Alfa Inbakicept-PMLN, chinyorwa che immunotherapy, chinoratidza vimbiso mukurapa gomarara redundira kana yasanganiswa neBCG therapy. Iyi nzira yekuvandudza yakanangana nemakaki egomarara uku ichisimudzira mhinduro ye immune system, ichiwedzera kushanda kwemishonga yechivanhu seBCG. Miedzo yemakiriniki inoratidza zvinokurudzira, zvichiratidza zvakavandudzwa mhedzisiro yemurwere uye kufambira mberi kunogona kuitika mukurapa kenza yedundira. Kuwirirana pakati peNogapendekin Alfa Inbakicept-PMLN neBCG kunozivisa nguva itsva mukurapa gomarara redundira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa